Elutia (Nasdaq: ELUT) granted inducement equity awards on May 13, 2026, under its 2026 Inducement Award Plan to one new employee, consistent with Nasdaq Listing Rule 5635(c)(4).
The grant consists of 48,000 non-qualified stock options at an exercise price of $1.05 per share, with four-year time-based vesting.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – ELUT
+1.82%
5 alerts
+1.82%Session close to close
+7.4%Peak in 24 hr 30 min
$51.28MMarket Cap
0.8xRel. Volume
In the May 19 session, ELUT gained 1.82%, reflecting a mild positive market reaction.
Argus tracked a peak move of +7.4% during that session.
Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.
This announcement details a standard inducement equity grant of 48,000 non-qualified stock options a...
Analysis
This announcement details a standard inducement equity grant of 48,000 non-qualified stock options at an exercise price of $1.05 for a new hire, vesting over four years. It follows earlier 2026 inducement awards and routine equity compensation activity. Investors may view it mainly as evidence of ongoing team building, with more attention likely focused on upcoming earnings dates, NXT-41 regulatory timelines, and execution of Elutia’s focused biomatrix strategy.
Key Figures
Inducement stock options:48,000 optionsInitial vesting tranche:25%Subsequent vesting period:3 years+1 more
4 metrics
Inducement stock options48,000 optionsGranted to one new employee under 2026 Inducement Award Plan
Initial vesting tranche25%Vests on first anniversary of vesting commencement date
Subsequent vesting period3 yearsRemaining options vest monthly over following three years
Exercise price$1.05 per shareClosing price on May 13, 2026 grant date
Regained compliance with Nasdaq minimum bid price and market value rules.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Stock reactions to news have mostly aligned with the tone of announcements, with one notable divergence on Nasdaq compliance news.
Recent Company History
Over the last few months, Elutia’s news flow has covered strategic shifts, regulatory progress, and capital markets compliance. A March 11 earnings and NXT-41 update coincided with a +5.5% move, while a March 4 Nasdaq compliance announcement saw a -2.46% reaction despite its positive nature. Earlier inducement awards on March 13 and conference participation on March 17 produced modest stock moves. Today’s additional inducement grant fits this pattern of routine corporate updates.
"was granted in accordance with Nasdaq Listing Rule 5635(c)(4)."
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
non-qualified stock optionsfinancial
"received an aggregate of 48,000 non-qualified stock options (the “Options”)."
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
exercise pricefinancial
"The Option had an exercise price of $1.05 per share, the closing price of"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it granted equity awards on May 13, 2026 to one new employee as an inducement award under the Elutia Inc. 2026 Inducement Award Plan (the “Plan”). The award was approved by the independent Compensation Committee of the Board of Directors and was granted in accordance with Nasdaq Listing Rule 5635(c)(4).
Under the Plan, the one new employee received an aggregate of 48,000 non-qualified stock options (the “Options”). The Options vest 25% on the first anniversary of the vesting commencement date, with the balance vesting in equal monthly installments over the following three years. Vesting is subject to each recipient’s continued employment through the applicable vesting date. The Option had an exercise price of $1.05 per share, the closing price of Elutia’s common stock on the Nasdaq Capital Market on May 13, 2026, the grant date. The Options are subject to the terms and conditions of the Plan and the applicable stock option agreement.
About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
What inducement stock option award did Elutia (NASDAQ: ELUT) announce on May 18, 2026?
Elutia announced an inducement grant of 48,000 non-qualified stock options to one new employee. According to Elutia, the grant was made under the 2026 Inducement Award Plan and approved by the independent Compensation Committee on May 13, 2026.
What are the vesting terms of Elutia’s 48,000 inducement stock options (ELUT)?
The options vest 25% on the first anniversary of the vesting commencement date, with the remainder vesting monthly over three years. According to Elutia, vesting is conditional on the employee’s continued employment through each applicable vesting date.
What is the exercise price of Elutia’s May 13, 2026 inducement options for ELUT stock?
The inducement options have an exercise price of $1.05 per share. According to Elutia, this price equals the closing price of its common stock on the Nasdaq Capital Market on May 13, 2026, the grant date.
Under which plan were Elutia’s May 2026 inducement stock options for ELUT granted?
The options were granted under the Elutia 2026 Inducement Award Plan. According to Elutia, the awards are subject to the plan’s terms and the applicable stock option agreement, and comply with Nasdaq Listing Rule 5635(c)(4) for inducement grants.
How does Nasdaq Listing Rule 5635(c)(4) relate to Elutia’s ELUT inducement award?
Elutia states the grant was made in accordance with Nasdaq Listing Rule 5635(c)(4), which permits equity awards as inducements for new employees. According to Elutia, this framework allowed the company to issue the options outside stockholder-approved plans.
What is the purpose of Elutia’s 2026 Inducement Award Plan for ELUT employees?
The 2026 Inducement Award Plan is used to grant equity awards to newly hired employees as an employment incentive. According to Elutia, the May 13, 2026 grant of 48,000 options was specifically made as an inducement award to one new employee.
